News & Updates
Filter by Specialty:
High-intensity statins help lower cholesterol among diabetics
Treatment with rosuvastatin, given at moderate and high intensity doses, as well as simvastatin and atorvastatin, given at high intensity doses, modestly reduce levels of nonhigh-density lipoprotein cholesterol (non-HDL-C) in diabetic patients over 12 weeks compared with placebo, a study has shown.
High-intensity statins help lower cholesterol among diabetics
05 Apr 2022
Resistance exercise could improve sleep duration, efficiency
Individuals at elevated cardiovascular disease risk (overweight/obese, increased blood pressure levels) may improve the duration and efficiency of their sleep through regular resistance exercise regimens, according to a study presented at the EPI Lifestyle Scientific Sessions 2022.
Resistance exercise could improve sleep duration, efficiency
04 Apr 2022
Allo-HSCT recipients at higher risk of metabolic diseases
Rigorous monitoring is necessary among recipients of allogeneic haematopoietic stem cell transplantation (allo-HSCT) for the development of metabolic diseases, such as hypertension, diabetes, dyslipidaemia, and cardiovascular disease (CVD), suggests a recent study.
Allo-HSCT recipients at higher risk of metabolic diseases
04 Apr 2022
Subclinical hyperthyroidism not a risk factor for MACE in PCI patients
Subclinical hyperthyroidism (SHyper) does not independently correlate with major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI), results of a study have shown.
Subclinical hyperthyroidism not a risk factor for MACE in PCI patients
04 Apr 2022
Depressive symptoms confer increased HFpEF hospitalization risk in absence of prevalent CHD
Depressive symptoms appear to put individuals who are free of coronary heart disease (CHD) at risk of hospitalization for heart failure with preserved ejection fraction (HFpEF) but not HF with reduced ejection fraction (HFrEF), a study has found.
